Advertisement

Topics

Progenitor Life Sciences LLC Company Profile

04:58 EDT 19th June 2018 | BioPortfolio

Progenitor Life Sciences provides unique and proprietary technologies to the rapidly growing immune oncology CAR-T development marketplace. The company is addressing key needs using proprietary genetic design approaches to enable next generation “off-the-shelf” allogeneic approaches, as well as, improved autologous approaches, to immune oncology CAR-T cell therapy development. The company’s products and technologies provide unique proprietary genetic design tools and cell constructs, which are used in the preclinical drug discovery and development process.


News Articles [1928 Associated News Articles listed on BioPortfolio]

Progenitor Life Sciences to Unveil Proprietary Next Generation “Off-the-Shelf” CAR-T Cell Development Workflow at the Biotech Showcase™ Annual Conference

Progenitor Life Sciences LLC today announced that it will present at Biotech Showcase™ 2018, January 8–10, during JPMorgan Healthcare Conference week. Gary R. ...

A bigger, better Office for Life Sciences

The Department for Business, Innovation and Skills (BIS) and the Department of Health (DH) are joining their life sciences functions to create a new, expanded Office for Life Sciences.BIS and DH have ...

Get the Inside Scoop on Seattle Life Sciences at Xconomy’s June Event

Xconomy’s annual Seattle-area life sciences conference will be held on June 12 at Cambia Grove in the Emerald City’s downtown. “What’s Hot in Seattle Biotech” will look at what’s hot, ...

NHSA makes arrangements to benefit life sciences industries across commonwealth countries

The NHSA has signed a memorandum of understanding (MoU) with Life Sciences Queensland (LSQ) in Australia and another with SCAN Health and World Health Innovation (WIN) in Canada to open up the commonw...

London Tops Europe for Life Sciences Investment in 2017

Investment in London’s life sciences companies reached almost £1B in 2017, beating the likes of Berlin and Paris to top spot. MedCity has carried out a study, which found that London’s ...

Why Data is the Key to Driving Closer Provider/Life Sciences Collaboration

Editor’s Note: John Pagliuca is Vice President, Life Sciences at SCIO Health Analytics, where he leads the global commercialization efforts of SCIO’s advanced analytics and SaaS solution suite...

AI: the foundation for life sciences 2.0?

How machine learning technology could significantly change the role played by life sciences in the future

TAE Life Sciences gets $40M boost

A round of venture capital funding pulled in $40 million for TAE Technologies subsidiary TAE Life Sciences.  -More- 

PubMed Articles [2901 Associated PubMed Articles listed on BioPortfolio]

RNA methylation regulates hematopoietic stem/progenitor cell specification.

A National Portrait of Stepfamilies in Later Life.

Scholars have documented increases in the prevalence and complexity of stepfamilies earlier in the life course, but no one has systematically investigated U.S. stepfamily structure in later life. Guid...

"It was the best worst day of my life": Narrative Content, Structure, and Process in Wisdom-Fostering Life Event Memories.

The purpose of this study was to examine laypeople's subjective understanding of their own wisdom development. To do this, autobiographical memories of wisdom-fostering life events were examined for (...

Educational Differences in the Prevalence of Dementia and Life Expectancy with Dementia: Changes from 2000 to 2010.

This article provides the first estimates of educational differences in age-specific prevalence, and changes in prevalence over time, of dementia by education levels in the United States. It also prov...

Purpose in Life Among Centenarian Offspring.

Purpose in life (PIL), a feeling of meaning and direction in life, is associated with favorable health outcomes including lower mortality and reduced risk of disease, disability, and cognitive impairm...

Clinical Trials [2266 Associated Clinical Trials listed on BioPortfolio]

Oligodendrocyte Progenitor Cell Culture From Human Brain

Recent developments in the understanding of stem- and progenitor cell differentiation raises hopes that brain damage in chronic neurological diseases may become repaired by systemic or foc...

Safety and Efficacy of Autologous Endothelial Progenitor Cell CD 133 for Therapeutic Angiogenesis

The purpose of this study is to determine whether transendocardial injections of autologous endothelial progenitor cells CD 133 is safe and feasible in patients with refractory angina.

Neural Progenitor Cell and Paracrine Factors to Treat Hypoxic Ischemic Encephalopathy

The purpose of this study is to investigate the efficacy and safety of allogenic neural progenitor cell and paracrine factors of human mesenchymal stem cells for patients with moderate/sev...

Safety and Efficacy of Intravitreal Injection of Human REtinal Progenitor Cells in Adults With Retinitis Pigmentosa

This study evaluates the changes in visual function at 12 months following a single injection of human retinal progenitor cells compared to untreated controls in a cohort of adult subjects...

Advance Care Planning at London Health Sciences Centre

All patients admitted to London Health Sciences Centre (LHSC) are asked to indicate their preferences for CPR (cardiopulmonary resuscitation) and other life-sustaining treatments that nece...

Companies [1993 Associated Companies listed on BioPortfolio]

Progenitor Life Sciences, LLC

Progenitor Life Sciences develops platform solutions for cellular immunotherapy and immune oncology. Our unique proprietary solutions include patented iPSC sourcing and immune-com...

Progenitor Life Sciences

Progenitor Life Sciences LLC

Progenitor Life Sciences provides unique and proprietary technologies to the rapidly growing immune oncology CAR-T development marketplace. The company is addressing key needs usi...

Life Sciences Pennsylvania

Life Sciences Pennsylvania is the statewide trade association for the life sciences in Pennsylvania and serves as a catalyst to ensure Pennsylvania is a global leader in the life ...

Central Life Sciences

Central Life Sciences is a strategic business unit of Central Garden & Pet (NASDAQ: CENT). Central Life Sciences is dedicated to creating healthier environments and making life better for people, ...

More Information about "Progenitor Life Sciences LLC" on BioPortfolio

We have published hundreds of Progenitor Life Sciences LLC news stories on BioPortfolio along with dozens of Progenitor Life Sciences LLC Clinical Trials and PubMed Articles about Progenitor Life Sciences LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Progenitor Life Sciences LLC Companies in our database. You can also find out about relevant Progenitor Life Sciences LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record